Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

2.690
+0.0602.28%
Volume:296.00K
Turnover:787.49K
Market Cap:1.66B
PE:-5.66
High:2.710
Open:2.630
Low:2.620
Close:2.630
52wk High:5.830
52wk Low:2.300
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:1.02
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.475
ROE:-242.61%
ROA:-18.75%
PB:-105.45
PE(LYR):-5.66
PS:- -

Loading ...

Immunotech Biopharm Signs Cell Therapy Processing Agreement with Tasly

Reuters
·
Jan 27

Immunotech Biopharm (6978) and Tasly (600535.SH) Reach Cell Therapy Service Agreement

Bulletin Express
·
Jan 27

Multiple Innovative Drugs Issue First Prescriptions Under New National Reimbursement Drug List, Lowering Patient Access Barriers

Deep News
·
Jan 27

SIHUAN PHARM (00460) Surges Over 9% Again as Institutions Favor Accelerated Dual Growth from Aesthetic and Innovation Drugs

Stock News
·
Jan 27

Three-Step Strategy for Health Insurance to Address Innovative Drug Payment

Deep News
·
Jan 26

Innovative Drug Out-Licensing Deals Remain Hot! Hong Kong Stock Connect Innovative Drug ETF (520880) Drops 1.5% with Sustained High Premium, Attracts 236 Million Yuan Inflows Last Week

Deep News
·
Jan 26

China's Innovative Drug BD Outbound Deals Set Historic Record, Hang Seng Innovation Drug ETF (520500) Sees Average Daily Turnover Exceeding 600 Million Since Year Start

Deep News
·
Jan 26

Hong Kong Stock Innovative Drug Concept Continues Rally, Akeso Surges Over 4%

Deep News
·
Jan 23

Another "Miracle Drug" for Growth? Can "Northeast Pharma Darling" Replicate Its "Hormone Legend"?

Deep News
·
Jan 22

CSC: China's Pharmaceutical Industry at the Starting Point of Global Value Reassessment, Bullish on Related Innovative Drugs and Pharmaceutical Companies

Stock News
·
Jan 22

Golden Eagle Fund's Ouyang Juan: Innovative Drugs Enter Performance Window, Brain-Computer Interface and AI Healthcare Revitalize Industry

Deep News
·
Jan 22

Hong Kong Stock Connect Innovative Drug ETF Suffers 6-Day Decline as Capital Continues Inflows! 520880 Attracts Over 100 Million Yuan Amid High Premium, Fund Units Reach Record 4.382 Billion

Deep News
·
Jan 22

Commercial Insurance Innovation Drugs Face Slow Pharmacy Sales While Hospital Penetration Accelerates for Certain Imported Medications

Deep News
·
Jan 21

Healthcare Giant Johnson & Johnson (JNJ.US) Withstands "Hundreds of Millions" Drug Pricing Hit, Issues Strong Outlook; Q4 Innovative Medicine Sales Rise 10%

Stock News
·
Jan 21

Great Wall Fund's Liang Furui: Many Innovative Drug Companies Now Offer Compelling Value

Deep News
·
Jan 21

BRIEF-Immunotech Biopharm Says Jiaze Global Capital To Subscribe For New Convertible Bonds, Note

Reuters
·
Jan 20

IMMUNOTECH-B (06978) Proposes Issuance of 270 Million Yuan New Convertible Bonds and 30 Million Yuan Notes to Jiazhe Global Capital for Repayment of 2023 Convertible Bonds Principal

Stock News
·
Jan 20

Immunotech Biopharm Ltd - Principal Amount of Notes RMB30 Mln

THOMSON REUTERS
·
Jan 20

Immunotech Biopharm - Jiaze Global Capital to Subscribe for New Convertible Bonds and Note

THOMSON REUTERS
·
Jan 20

Immunotech Biopharm Announces RMB300 Million Convertible Bonds and Note Issuance

Reuters
·
Jan 20